Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Trevisani

Showing results (171-180 of 208) with videos related to

Pageof 21
Sort By:
The International Journal of Biological Markers|March 1, 2021
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameterBrian I Carr, Vito Guerra, Rossella Donghia, et al.
Frontiers in Oncology|February 17, 2022
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative TreatmentFilippo Pelizzaro, Selion Haxhi, Barbara Penzo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 27, 2023
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resectionFilippo Pelizzaro, Franco Trevisani, Vittorio Simeon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2016
The evolutionary scenario of hepatocellular carcinoma in Italy: an updateLaura Bucci, Francesca Garuti, Barbara Lenzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 31, 2022
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinomaEdoardo G Giannini, Giulia Pieri, Sara Labanca, et al.
Journal of Hepatology|March 9, 2016
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER studyMichael Bitzer, Marius Horger, Edoardo G Giannini, et al.
Plos Medicine|April 27, 2016
Development and Validation of a New Prognostic System for Patients with Hepatocellular CarcinomaFabio Farinati, Alessandro Vitale, Gaya Spolverato, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practiceEdoardo Giovanni Giannini, Laura Bucci, Francesca Garuti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 28, 2021
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survivalFilippo Pelizzaro, Giulia Peserico, Marco D'Elia, et al.
Liver Cancer|May 12, 2021
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationClaudia Campani, Alessandro Vitale, Gabriele Dragoni, et al.
Pageof 21

Showing results (171-180 of 208) with videos related to

Sort By:
Pageof 21
The International Journal of Biological Markers|March 1, 2021
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameterBrian I Carr, Vito Guerra, Rossella Donghia, et al.
Frontiers in Oncology|February 17, 2022
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative TreatmentFilippo Pelizzaro, Selion Haxhi, Barbara Penzo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 27, 2023
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resectionFilippo Pelizzaro, Franco Trevisani, Vittorio Simeon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2016
The evolutionary scenario of hepatocellular carcinoma in Italy: an updateLaura Bucci, Francesca Garuti, Barbara Lenzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 31, 2022
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinomaEdoardo G Giannini, Giulia Pieri, Sara Labanca, et al.
Journal of Hepatology|March 9, 2016
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER studyMichael Bitzer, Marius Horger, Edoardo G Giannini, et al.
Plos Medicine|April 27, 2016
Development and Validation of a New Prognostic System for Patients with Hepatocellular CarcinomaFabio Farinati, Alessandro Vitale, Gaya Spolverato, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practiceEdoardo Giovanni Giannini, Laura Bucci, Francesca Garuti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 28, 2021
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survivalFilippo Pelizzaro, Giulia Peserico, Marco D'Elia, et al.
Liver Cancer|May 12, 2021
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationClaudia Campani, Alessandro Vitale, Gabriele Dragoni, et al.
Pageof 21